Waystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter

2 hours ago 1

Jonathan Ponciano, The Motley Fool

Sun, March 15, 2026 astatine 10:43 AM CDT 4 min read

Blue Door Asset Management disclosed a February 17, 2026, acquisition of 322,600 shares of Waystar (NASDAQ:WAY), an estimated $11.49 cardinal commercialized based connected quarterly mean pricing.

According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Blue Door Asset Management accrued its presumption successful Waystar by 322,600 shares. The estimated transaction worth for the 4th was $11.49 million, calculated utilizing the mean unadjusted closing terms during the period. At quarter-end, the position’s worth accrued by $10.15 million, reflecting some the stock acquisition and changes successful stock price.

Top 5 money holdings aft the report:
- NASDAQ: FLEX: $23.49 cardinal (14.7% of AUM)
- NYSE: EPAM: $18.38 cardinal (11.5% of AUM)
- NASDAQ: NICE: $16.15 cardinal (10.1% of AUM)
- NASDAQ:WAY: $13.18 cardinal (8.3% of AUM)
- NASDAQ: NXT: $13.15 cardinal (8.2% of AUM)
As of Friday, Waystar shares were priced astatine $24.16, down 31.5% implicit the past twelvemonth and good underperforming the S&P 500’s astir 20% summation successful the aforesaid period.

Metric

Value

Revenue (TTM)	$1.10 billion
Net income (TTM)	$112.09 million
Price (as of Friday)	$24.16
One-year terms change	(31.5%)

Waystar delivers a cloud-based bundle level for healthcare payments, offering solutions for fiscal clearance, diligent fiscal care, claims and outgo management, denial prevention and recovery, gross capture, and analytics.
Its concern exemplary centers connected providing SaaS solutions to healthcare providers and organizations seeking to optimize gross rhythm management.
Waystar serves a wide lawsuit basal of healthcare providers, hospitals, and wellness systems crossed the United States.

Waystar operates astatine standard successful the healthcare exertion sector, leveraging a robust SaaS level to code analyzable outgo and gross rhythm challenges for healthcare providers. The company's integrated solutions and analytics capabilities presumption it arsenic a cardinal spouse for clients aiming to amended fiscal show and efficiency. With a absorption connected innovation and automation, Waystar seeks to support a competitory borderline successful the rapidly evolving healthcare IT landscape.

Waystar’s latest results item wherefore the concern mightiness person attracted immoderate much superior from Blue Door contempt its precocious anemic banal performance. The institution reported $1.10 cardinal successful gross for 2025, up 17% twelvemonth implicit year, portion adjusted EBITDA reached astir $462 million, up 21% twelvemonth implicit twelvemonth and reflecting beardown margins for a bundle level serving healthcare providers. Meanwhile, fourth-quarter gross climbed 24% to astir $304 million, showing continued momentum arsenic providers follow automation tools to negociate gross cycles much efficiently.

The stock’s astir 31% diminution implicit the past twelvemonth stands retired fixed that maturation profile, but it’s not astonishing fixed however punishing the marketplace has been to bundle stocks amid increasing concerns implicit artificial quality and its interaction connected the sector.

Within the broader portfolio, Waystar ranks among the fund’s larger holdings astatine much than 8% of assets, though inactive smaller than positions similar Flex and EPAM. Ultimately, that positioning signals condemnation successful healthcare bundle and a penchant for diversification crossed endeavor exertion and integer infrastructure. With Waystar projecting further maturation adjacent year, including gross of astir $1.28 cardinal and adjusted EBITDA of $535 cardinal astatine the midpoint, it becomes casual to recognize wherefore a money similar Blue Door would beryllium doubling down close now.

Read Entire Article